Alzheimer's disease (AD) is one of the most common and challenging neurodegenerative diseases globally. It mostly affects older adults, causing irreversible changes in the brain that result in the progression of dementia, behavioral impairments, and worsening of daily living skills. Although Alzheimer's disease has been studied for over a century, there is still no effective treatment. Recent research demonstrated by interdisciplinary team of scientists from the Institute of Physical Chemistry, Polish Academy of Sciences in Poland and University of Burgos in Spain, highlight the important role of using combined analytical techniques to investigate potential drug candidates. They show how a novel molecule – TDMQ20 – that is proposed as a drug to treat AD, interacts with copper ions, decreasing the harmful effect on neurons. Let’s take a closer look at their breakthrough.

BUFFALO, NY — December 8, 2025 — A new research paper was published in Volume 17, Issue 11 of Aging-US on September 12, 2025, titled “Infusion of blood from young and old mice modulates amyloid pathology.”

Simon Fraser University researchers are laying the groundwork for an innovative long-term care model that combines nature-based therapy with village-setting care to enhance the quality of life for people living with dementia. First developed on traditional farms in the Netherlands, the Green Care Farm (GCF) model integrates long-term care with farm-related activities in a therapeutic setting to foster autonomy, cognitive stimulation, and emotional well-being for people living with dementia. Now, a first-of-its-kind research project is bringing this model to Canada.